ITMCTR2000002901
Not yet recruiting
Phase 4
A multicenter, randomized, controlled, trial for efficacy of Chang-Yan-Ning granules in the treatment of functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University0 sitesTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)
- Sponsor
- Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Informed consent signed by the patient;
- •2\. Aged 18\-65 years old;
- •3\. The Rome IV diagnostic criteria clearly diagnosed as diarrheal irritable bowel syndrome (ibs\-d) or functional diarrhea (FDi);
- •4\. Discontinuation of contravention medications for abdominal symptoms or diarrhea in the pre\-treatment phase;
- •5\. No major changes in the patient's lifestyle during the visit that might affect the symptoms of diarrhoea (for example, starting a new diet, or changing normal exercise patterns);
- •6\. Colonoscopy in domestic tertiary hospitals or above within two years reported normal results or abnormal results that researchers considered to be of no clinical significance, such as chronic colitis diagnosed due to congestion and edema, but no bleeding fecal erosion ulcer, colon polyps of less than 3mm in diameter and less than 5 in number.
Exclusion Criteria
- •1\. Organic diseases of the intestine, such as inflammatory bowel disease, intestinal tuberculosis, malabsorption syndrome, celiac disease, lactose intolerance or other organic diseases;
- •2\. Previous history of abdominal and pelvic surgery, such as cholecystectomy, etc. (except for appendectomy, patients without intestinal complications such as intestinal obstruction after c\-section, and endoscopic treatment of intestinal polyps);
- •3\. Chronic pancreatitis, tumor, peptic ulcer, tuberculous peritonitis, cirrhosis and other diseases of the digestive system (patients with chronic cholecystitis diagnosed by b\-mode ultrasound can be included if there is no typical gallbladder colic);
- •4\. Abnormal stool routine results: occult blood in stool (\+) or white blood cells (\+);
- •5\. Have other serious systemic diseases, including severe lesions of heart, lung, kidney and other important organs, immunoregulatory diseases, metabolic diseases (diabetes, hyperthyroidism or hypothyroidism) or malignant tumors, reproductive diseases such as ovarian cysts, endometriosis, etc.;
- •6\. During the experiment, it is impossible to stop the concomitant drugs that affect the gastrointestinal movement and function, such as antibiotics, intestinal microecological preparations, proton pump inhibitors, etc.;
- •7\. Pregnant or lactating patients;
- •8\. Less than 3 months after participating in or completing other clinical trials;
- •9\. Other researchers think not suitable for candidates.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 4
A multicenter, randomized controlled trial of entecavir treatment for the patients with hepatocellular carcinoma complicated with chronic hepatitis B or cirrhosis after a curative treatment of the cancer: Anti-virus effect, influence on hepatic reserve, cancer recurrence, and survival.Chronic hepatitis B and cirrhosis after a curative treatment of hepatocellular carcinomaJPRN-UMIN000000597Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences170
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Recruiting
Not Applicable
A multicenter randomized controlled trial on the efficacy of trans arterial cooling infusion with endovascular therapy for acute ischemic strokeacute ischemic strokeJPRN-UMIN000039851ippon Medical School120
Recruiting
Phase 1
A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategysevere novel coronavirus pneumonia (COVID-19)ITMCTR2000003002Huangshi Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 4
A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategyITMCTR2000003019Huangshi Hospital of Traditional Chinese Medicine